Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Experimental Physiology
|
August 2, 2011
Progress in therapy for Duchenne muscular dystrophy
Rebecca J Fairclough, Akshay Bareja, Kay E Davies
Current Gene Therapy
|
May 11, 2012
Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy
Rebecca J Fairclough, Kelly J Perkins, Kay E Davies
Nature Reviews. Genetics
|
April 24, 2013
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
Rebecca J Fairclough, Matthew J Wood, Kay E Davies
Clinical and Translational Medicine
|
May 20, 2022
Clinic-ready inhibitor of MMP-9/-12 restores sensory and functional decline in rodent models of spinal cord injury
Zubair Ahmed, Sharif Alhajlah, Adam M Thompson, et al.
Microbiology (Reading, England)
|
September 7, 2000
The replication and stable-inheritance functions of IncP-9 plasmid pM3
Alicia Greated, Marina Titok, Renata Krasowiak, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 15, 2021
Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development
Andrew M Davis, Ola Engkvist, Rebecca J Fairclough, et al.
The Journal of Biological Chemistry
|
April 16, 2005
The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions
Jo Vanoevelen, Leonard Dode, Kurt Van Baelen, et al.
The Journal of Investigative Dermatology
|
June 12, 2004
Hailey-Hailey disease: identification of novel mutations in ATP2C1 and effect of missense mutation A528P on protein expression levels
Rebecca J Fairclough, Lorne Lonie, Kurt Van Baelen, et al.
The Journal of Biological Chemistry
|
April 23, 2003
Effect of Hailey-Hailey Disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1)
Rebecca J Fairclough, Leonard Dode, Jo Vanoevelen, et al.
Biochemical Pharmacology
|
August 22, 2024
Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants
Brian E Ford, Shruti S Chachra, Ahmed Alshawi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Experimental Physiology
|
August 2, 2011
Progress in therapy for Duchenne muscular dystrophy
Rebecca J Fairclough, Akshay Bareja, Kay E Davies
Current Gene Therapy
|
May 11, 2012
Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy
Rebecca J Fairclough, Kelly J Perkins, Kay E Davies
Nature Reviews. Genetics
|
April 24, 2013
Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches
Rebecca J Fairclough, Matthew J Wood, Kay E Davies
Clinical and Translational Medicine
|
May 20, 2022
Clinic-ready inhibitor of MMP-9/-12 restores sensory and functional decline in rodent models of spinal cord injury
Zubair Ahmed, Sharif Alhajlah, Adam M Thompson, et al.
Microbiology (Reading, England)
|
September 7, 2000
The replication and stable-inheritance functions of IncP-9 plasmid pM3
Alicia Greated, Marina Titok, Renata Krasowiak, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 15, 2021
Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development
Andrew M Davis, Ola Engkvist, Rebecca J Fairclough, et al.
The Journal of Biological Chemistry
|
April 16, 2005
The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions
Jo Vanoevelen, Leonard Dode, Kurt Van Baelen, et al.
The Journal of Investigative Dermatology
|
June 12, 2004
Hailey-Hailey disease: identification of novel mutations in ATP2C1 and effect of missense mutation A528P on protein expression levels
Rebecca J Fairclough, Lorne Lonie, Kurt Van Baelen, et al.
The Journal of Biological Chemistry
|
April 23, 2003
Effect of Hailey-Hailey Disease mutations on the function of a new variant of human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1)
Rebecca J Fairclough, Leonard Dode, Jo Vanoevelen, et al.
Biochemical Pharmacology
|
August 22, 2024
Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants
Brian E Ford, Shruti S Chachra, Ahmed Alshawi, et al.
Page
of 2